Literature DB >> 14759799

Efficient gene transfer to hematopoietic repopulating cells using concentrated RD114-pseudotype vectors produced by human packaging cells.

Tobias Neff, Laura J Peterson, Julia C Morris, Jesse Thompson, Xiaobing Zhang, Peter A Horn, Bobbie M Thomasson, Hans-Peter Kiem.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14759799     DOI： 10.1016/j.ymthe.2003.11.011

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  17 in total

1.  Combination of HOXB4 and Delta-1 ligand improves expansion of cord blood cells.

Authors:  Korashon L Watts; Colleen Delaney; R Keith Humphries; Irwin D Bernstein; Hans-Peter Kiem
Journal:  Blood       Date:  2010-10-04       Impact factor: 22.113

Review 2.  Hematopoietic-stem-cell-based gene therapy for HIV disease.

Authors:  Hans-Peter Kiem; Keith R Jerome; Steven G Deeks; Joseph M McCune
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

Review 3.  Survival of the fittest: in vivo selection and stem cell gene therapy.

Authors:  Tobias Neff; Brian C Beard; Hans-Peter Kiem
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

4.  RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.

Authors:  Anna Stornaiuolo; Bianca Maria Piovani; Sergio Bossi; Eleonora Zucchelli; Stefano Corna; Francesca Salvatori; Fulvio Mavilio; Claudio Bordignon; Gian Paolo Rizzardi; Chiara Bovolenta
Journal:  Hum Gene Ther Methods       Date:  2013-08-03       Impact factor: 2.396

5.  Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells.

Authors:  Grant D Trobridge; Robert A Wu; Michael Hansen; Christina Ironside; Korashon L Watts; Philip Olsen; Brian C Beard; Hans-Peter Kiem
Journal:  Mol Ther       Date:  2009-12-08       Impact factor: 11.454

6.  Stable gammaretroviral vector expression during embryonic stem cell-derived in vitro hematopoietic development.

Authors:  Ali Ramezani; Teresa S Hawley; Robert G Hawley
Journal:  Mol Ther       Date:  2006-05-30       Impact factor: 11.454

7.  A novel SIV gag-specific CD4(+)T-cell clone suppresses SIVmac239 replication in CD4(+)T cells revealing the interplay between antiviral effector cells and their infected targets.

Authors:  Victor I Ayala; Matthew T Trivett; Lori V Coren; Sumiti Jain; Patrick S Bohn; Roger W Wiseman; David H O'Connor; Claes Ohlen; David E Ott
Journal:  Virology       Date:  2016-03-25       Impact factor: 3.616

8.  Adoptive Transfer of Engineered Rhesus Simian Immunodeficiency Virus-Specific CD8+ T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus Macaques.

Authors:  Victor I Ayala; Matthew T Trivett; Eugene V Barsov; Sumiti Jain; Michael Piatak; Charles M Trubey; W Gregory Alvord; Elena Chertova; James D Roser; Jeremy Smedley; Alexander Komin; Brandon F Keele; Claes Ohlen; David E Ott
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

9.  Preferential Small Intestine Homing and Persistence of CD8 T Cells in Rhesus Macaques Achieved by Molecularly Engineered Expression of CCR9 and Reduced Ex Vivo Manipulation.

Authors:  Matthew T Trivett; James D Burke; Claire Deleage; Lori V Coren; Brenna J Hill; Sumiti Jain; Eugene V Barsov; Matthew W Breed; Joshua A Kramer; Gregory Q Del Prete; Jeffrey D Lifson; Adrienne E Swanstrom; David E Ott
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

10.  Production of retroviral constructs for effective transfer and expression of T-cell receptor genes using Golden Gate cloning.

Authors:  Lori V Coren; Sumiti Jain; Matthew T Trivett; Claes Ohlen; David E Ott
Journal:  Biotechniques       Date:  2015-03-01       Impact factor: 1.993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.